WS Data Solutions
Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Genelux Corporation Common Stock (GNLX)
Pharmaceutical Preparations
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/26/2023
Market Cap
69,390,973
Shares Outstanding
26,720,000
Weighted SO
26,717,676
Total Employees
N/A
Upcoming Earnings
08/12/2024
Beta
-3.1651
Last Div
0.0000
Range
1.6-30.44
Chg
-0.1100
Avg Vol
287708
Mkt Cap
69390973
Exch
NASDAQ
Country
US
Phone
858 483 0024
DCF Diff
1.7215
DCF
0.2885
Div Yield
0.0000
P/S
47.1406
EV Multiple
-2.4118
P/FV
1.5921
Div Yield %
0.0000
P/E
-2.2599
PEG
0.0050
Payout
0.0000
Current Ratio
6.0090
Quick Ratio
6.0090
Cash Ratio
1.3541
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
1888.5297
CCC
-1888.5297
Gross Margin
0.3716
Op Margin
-18.5564
Pretax Margin
-18.0285
Net Margin
-18.0285
Eff Tax Rate
0.1456
ROA
-0.5874
ROE
-1.1028
ROCE
-0.6937
NI/EBT
1.0000
EBT/EBIT
0.9716
EBIT/Rev
-18.5564
Debt Ratio
0.0489
D/E
0.0586
LT Debt/Cap
0.0434
Total Debt/Cap
0.0553
Int Coverage
-569.0625
CF/Debt
-9.7168
Equity Multi
1.1994
Rec Turnover
0.0000
Pay Turnover
0.1933
Inv Turnover
0.0000
FA Turnover
0.4324
Asset Turnover
0.0326
OCF/Share
-0.7223
FCF/Share
-0.7485
Cash/Share
1.1329
OCF/Sales
-14.5686
FCF/OCF
1.0363
CF Coverage
-9.7168
ST Coverage
-42.8900
CapEx Coverage
-27.5643
Div&CapEx Cov
-27.5643
P/BV
1.5921
P/B
1.5921
P/S
47.1406
P/E
-2.2599
P/FCF
-3.1225
P/OCF
-2.7966
P/CF
-2.7966
PEG
0.0050
P/S
47.1406
EV Multiple
-2.4118
P/FV
1.5921
DPS
0.0000